ArticleClinical and translational medicine2026
CDO1 as a prognostic biomarker and therapeutic target in gastric cancer: Mechanistic insights into the PI3K/AKT-THBS1 axis and epigenetic reactivation by decitabine.
Fazhi Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.